MEPROBAMATE SUMMARY
Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
|
|
NEWS HIGHLIGHTSMedia Articles Related to Meprobamate
Chronic Pain Common in Adults With Depression, Anxiety Source: MedicineNet Bipolar Disorder Specialty [2017.06.07] Title: Chronic Pain Common in Adults With Depression, Anxiety Category: Health News Created: 6/6/2017 12:00:00 AM Last Editorial Review: 6/7/2017 12:00:00 AM
Generalized Anxiety Disorder Source: MedicineNet alprazolam Specialty [2017.05.30] Title: Generalized Anxiety Disorder Category: Symptoms and Signs Created: 2/20/2014 12:00:00 AM Last Editorial Review: 5/30/2017 12:00:00 AM
Anxiety Source: MedicineNet Holiday Depression And Stress Specialty [2017.05.01] Title: Anxiety Category: Symptoms and Signs Created: 10/13/2003 12:00:00 AM Last Editorial Review: 5/1/2017 12:00:00 AM
Anxiety Disorder Pictures: Symptoms, Panic Attacks, and More with Pictures Source: MedicineNet temazepam Specialty [2016.06.09] Title: Anxiety Disorder Pictures: Symptoms, Panic Attacks, and More with Pictures Category: Slideshows Created: 2/2/2012 12:00:00 AM Last Editorial Review: 6/9/2016 12:00:00 AM
Positive Topline Results for Cannabinoid Gel in Fragile X Source: Medscape NeurologyHeadlines [2017.09.29] An investigational transdermal cannabinoid gel led to significant and clinically meaningful improvement in anxiety and difficult behaviors in a phase 2 study of children with fragile X syndrome. Medscape Medical News
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06] Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
Reports of Suspected Meprobamate Side Effects
Toxicity TO Various Agents (28),
Respiratory Arrest (15),
Cardiac Arrest (15),
Accidental Death (14),
Drug Abuse (11),
Completed Suicide (11),
Death (5),
Multiple Drug Overdose Accidental (5),
Pulmonary Congestion (5),
Pulmonary Oedema (4), more >>
|
|
Page last updated: 2017-09-29
|